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Recent studies demonstrate that natural killer (NK)
cells have adaptive immune features. Here, we
investigated the role of the costimulatory molecule
DNAM-1 in the differentiation of NK cells in a mouse
model of cytomegalovirus (MCMV) infection. Anti-
body blockade of DNAM-1 suppressed the expan-
sion of MCMV-specific Ly49H+ cells during viral
infection and inhibited the generation of memory
NK cells. Similarly, DNAM-1-deficient (Cd226/)
Ly49H+ NK cells exhibited intrinsic defects in expan-
sion and differentiation into memory cells. Src-family
tyrosine kinase Fyn and serine-threonine protein
kinase C isoform eta (PKCh) signaling through
DNAM-1 played distinct roles in the generation of
MCMV-specific effector and memory NK cells.
Thus, cooperative signaling through DNAM-1 and
Ly49H are required for NK cell-mediated host de-
fense against MCMV infection.
INTRODUCTION
Natural killer (NK) cells are traditionally classified as innate im-
mune cells because they rapidly respond to pathogens and are
considered short-lived and unable to differentiate into memory
cells (Lanier, 2005; Min-Oo et al., 2013; Sun et al., 2010). Accu-
mulating evidence, however, indicates that NK cells have adap-
tive immune features (Cooper et al., 2009; Min-Oo et al., 2013;
O’Leary et al., 2006; Paust et al., 2010; Sun et al., 2009, 2010,
2011). In some cases, NK cells are activated after exposure to
pathogens, antigens, and cytokines and subsequently differen-
tiate into a long-lived population with enhanced effector function
in response to a variety of secondary stimuli, as compared with
naive NK cells (Cooper et al., 2009; O’Leary et al., 2006; Sun
et al., 2009). The existence of memory NK cells in humans is sug-
gested by the extensive expansion and persistence for months
of NKG2C+ NK cells after infection with human cytomegalovirus
(HCMV) (Foley et al., 2012a, 2012b; Lopez-Verge`s et al., 2011;Min-Oo et al., 2013). We have previously demonstrated that
mouse NK cells bearing the Ly49H receptor, which specifically
recognizes the m157mouse cytomegalovirus (MCMV) glycopro-
tein on the infected cells (Arase et al., 2002), undergo activation,
a robust expansion, contraction, differentiation into a long-lived
memory subset, and persistence in both lymphoid and nonlym-
phoid organs for severalmonths afterMCMV infection (Sun et al.,
2009, 2010). These memory NK cells are capable of mounting a
recall response to MCMV infection and protect the host better
than naive NK cells (Sun et al., 2009). The kinetics of differentia-
tion of Ly49H+ NK cells during MCMV infection are similar to
virus-specific CD8+ T cells. NK cells and CD8+ T cells arise
from a common lymphoid progenitor, express many shared
cell surface antigens, secrete a similar array of cytokines, and
most importantly, perform common functions including perforin-
and granzyme-mediated cytotoxicity (Sun et al., 2009, 2011; Sun
and Lanier, 2011). Although DAP12 adaptor protein ITAM-medi-
ated signaling through Ly49H and the proinflammatory cytokine
interleukin-12 (IL-12) are known to be essential for optimal
expansion of effector Ly49H+ NK cells and for the generation
of memory Ly49H+ NK cells during MCMV infection (Sun et al.,
2009, 2012), the contribution of signaling through other recep-
tors required for the differentiation of MCMV-specific NK cells
have not been defined.
DNAM-1 (DNAX accessory molecule-1, CD226) is a costimu-
latory molecule that is constitutively expressed by NK cells and
CD8+ T cells (Shibuya et al., 1996). DNAM-1 recognizes CD155
and its related family member, CD112, as cognate ligands (Bot-
tino et al., 2003; Tahara-Hanaoka et al., 2004), which are broadly
expressed by hematopoietic, epithelial, and endothelial cells in
many tissues (Aoki et al., 1997; Nabekura et al., 2010; Ravens
et al., 2003). DNAM-1 has signal-transducing motifs in its cyto-
plasmic domain for the recruitment of the tyrosine kinases Fyn
and serine-threonine kinase PKC (Shibuya et al., 1998, 1999;
Shirakawa et al., 2005, 2006). Interaction between DNAM-1 on
NK cells and CD8+ T cells with its ligands on target cells triggers
cell-mediated cytotoxicity and cytokine production (Bottino
et al., 2003; Iguchi-Manaka et al., 2008; Shibuya et al., 1996).
DNAM-1 is also involved in NK cell- and CD8+ T cell-mediated
tumor rejection, as demonstrated with transplantable tumor
models but also in immune surveillance of carcinogen-inducedImmunity 40, 225–234, February 20, 2014 ª2014 Elsevier Inc. 225
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Figure 1. Phenotype of DNAM-1+ and DNAM-1– NK Cells
(A) Expression of DNAM-1 on NK cells in the spleen, blood, BM, and liver,
gating on TCRbNK1.1+ lymphocytes. Thin and bold lines represent staining
with control Ig and anti-DNAM-1 mAb.
(B) Developmental stages of DNAM-1+ and DNAM-1 NK cells as determined
by costaining with CD27 and CD11b, gating on TCRbNK1.1+ lymphocytes.
(C) Ly49H expression on DNAM-1+ (thick lines) and DNAM-1 (thin lines)
NK cells, gated on TCRbNK1.1+ lymphocytes. Percentages of Ly49H+ NK
cells in DNAM-1+ (bold numbers) and DNAM-1 (thin numbers) NK cells are
shown.
(D) Expression of Ly49C and/or Ly49I on DNAM-1+ (thick lines) and DNAM-1
(thin lines) NK cells. Data are representative of two to four experiments.
(E) IFN-g production and degranulation of Ly49H+DNAM-1+ and Ly49H+
DNAM-1NK cells after coculture with RMA cells expressingm157, CD155, or
m157 and CD155. Data are representative of two independent experiments
(n = 3–6 per experiment).
(F) WT splenocytes (2.53 107) were transferred into DAP12-deficient mice and
infected with 1 3 105 pfu MCMV. IFN-g production by Ly49H+ NK cells was
analyzed by intracellular staining on day 1.5 pi. Percentages of IFN-g+Ly49H+
NK cells and mean fluorescent intensity (MFI) of IFN-g of Ly49H+ NK cells
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226 Immunity 40, 225–234, February 20, 2014 ª2014 Elsevier Inc.tumorigenesis (Iguchi-Manaka et al., 2008; Tahara-Hanaoka
et al., 2006). Recently, DNAM-1 has been shown to costimulate
the proliferation and interferon-g (IFN-g) production of alloan-
tigen-specific CD8+ T cells (Nabekura et al., 2010). Thus,
DNAM-1 plays a critical role in the functions of NK cells and
CD8+ T cells for the elicitation of appropriate immune responses.
Here, by using the well-established model of MCMV infection
(Sun et al., 2009), we investigated the role of DNAM-1 in the dif-
ferentiation and function of MCMV-specific memory NK cells.
RESULTS
DNAM-1 Is Expressed on Immature andMature NK Cells
We examined whether DNAM-1 correlates with the maturation
stage of NK cells or is required for NK cell-mediated effector
functions in vitro. Approximately 80%–90% of NK cells in the
spleen, blood, bone marrow (BM), and liver of C57BL/6 mice ex-
pressed DNAM-1 (Figure 1A). Similar frequencies of immature
(CD27+CD11b), intermediate (CD27+CD11b+), and mature
(CD27CD11b+) NK cells were present within the DNAM-1+
and DNAM-1 subsets (Figure 1B). DNAM-1 and DNAM-1+
NK cells expressed equivalent amounts of IL-2 receptor b and
g subunits, IL-7Ra, and IFN-aR1 (not shown). The Ly49H recep-
tor was expressed on a higher frequency of DNAM-1 NK cells
(60%–85% Ly49H+) compared with DNAM-1+ NK cells
(40%–50% Ly49H+) (Figure 1C). Within the DNAM-1 and
DNAM-1+ Ly49H+ NK cell subsets, the frequency of NK cells ex-
pressing Ly49C and/or Ly49I, inhibitory receptors that recognize
self H-2b ligands (marking licensed NK cells), was identical
(Figure 1D).
Ly49H specifically recognizes the MCMV-encoded m157
glycoprotein (Arase et al., 2002; Smith et al., 2002). Similar fre-
quencies of DNAM-1 and DNAM-1+ Ly49H+ degranulated
and produced IFN-g when cocultured with RMA target cells
transduced to express m157 (Figure 1E). Coexpression of
CD155, a ligand of DNAM-1, on the m157+ RMA cells did not in-
crease the frequency of Ly49H+ NK cells degranulating or pro-
ducing IFN-g. In a similar fashion we adoptively transferred
wild-type (WT) Ly49H+ NK cells into syngeneic DAP12-deficient
recipient mice, which lack functionally competent Ly49H+ NK
cells and are unable to control early replication of MCMV (Sjo¨lin
et al., 2002; Sun et al., 2009). After infection with MCMV, both
DNAM-1 and DNAM-1+ Ly49H+ NK cells produced IFN-g on
day 1.5 postinfection (pi) (Figure 1F). These findings demonstrate
that DNAM-1 is not required for m157-induced degranulation or
cytokine production by Ly49H+ NK cells.
DNAM-1 Antibody Blockade Suppresses the NK Cell
Response to MCMV
We addressed the role of DNAM-1 in the control of MCMV by
treating C57BL/6 mice with a nondepleting, neutralizing anti-
DNAM-1 mAb 1 day prior to infection and measured viral titers
on day 3, when NK cells are predominantly responsible for anti-
viral immunity. Blocking DNAM-1 resulted in a significant in-
crease in viral load in the spleen and liver (Figure 2A).within the DNAM-1+ and DNAM-1 Ly49H+ NK cell subsets are shown. Data
are representative of three experiments (n = 34 mice per experiment).
Error bars show SEM. *p < 0.05.
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Figure 2. DNAM-1 Antibody Blockade Sup-
presses the NK Cell Response to MCMV
(A) WT mice were inoculated with control Ig or a
neutralizing mAb against DNAM-1 on the day
before infection with 5 3 105 pfu MCMV. Viral
burden in the liver and spleen was measured on
day 3 pi.
(B) WT Ly49H+ NK cells (1 3 105) were transferred
into DAP12-deficient mice and infected with 1 3
105 pfu MCMV. Mice were inoculated with 100 mg
control Ig or anti-DNAM-1 mAb on the day before
infection and day 3 pi. The absolute number of
Ly49H+ NK cells per ml blood is shown.
(C) DAP12-deficient mice receiving 1 3 105 WT
Ly49H+ NK cells were infected with MCMV and
treatedwith 100 mg control Ig or anti-DNAM-1mAb
on days 7, 14, and 21 pi. The absolute number of
Ly49H+ NK cells per ml blood and percentages of
Ly49H+memory NK cells in the spleen on day 28 pi
are shown.
Data were pooled from two experiments (n = 6
mice per mAb group). Error bars show SEM. *p <
0.05, **p < 0.01. See also Figure S1.
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DNAM-1 Regulates the Generation of Memory NK CellsLy49H+ NK cells preferentially expand after MCMV infection
and are required for early control of viral replication (Brown
et al., 2001; Dokun et al., 2001; Lee et al., 2001). When a limiting
number of Ly49H+ NK cells are adoptively transferred into
Ly49H-deficient mice and infected with MCMV, these Ly49H+
NK cells undergo extensive expansion and give rise to memory
Ly49H+ NK cells (Sun et al., 2009). Monitoring of donor Ly49H+
NK cells in the blood reflects the responses in the spleen and
liver, as previously demonstrated (Sun et al., 2010). Memory
Ly49H+ NK cells can be operationally defined as KLRG1hi,
CD11b+, CD27, Ly6Chi Ly49H+ NK cells that persist for more
than 25 days after infection with MCMV. To determine the effect
of DNAM-1 blockade on the clonal expansion of Ly49H+ NK
cells and generation of memory NK cells, we enriched NK cells
and adoptively transferred wild-type (WT) Ly49H+ NK cells into
syngeneic DAP12-deficient recipient mice (Figure S1 available
online). These mice were injected with a neutralizing anti-
DNAM-1 mAb on the day before infection and on day 3 pi.
Expansion of donor Ly49H+ NK cells at the peak of the NK
cell response during MCMV infection was suppressed by
anti-DNAM-1 antibody (Figure 2B); however, Ly49H+ NK cells
were detected at day 28 in the mice treated with anti-DNAM-1
on days 1 and 3 pi. These NK cells were able to undergo a
secondary response when adoptively transferred into naive
Ly49H-deficient recipients and challenged with MCMV (not
shown). Therefore, to address whether DNAM-1 antibody
blockade affects the persistence of Ly49H+ NK cells after the
peak of the response, Ly49H+ NK cells were adoptively trans-
ferred into DAP12-deficient recipients that were then infected
with MCMV and mice were treated with control Ig or neutral-
izing anti-DNAM-1 on days 7, 14, and 21 pi and analyzed on
day 28 pi. Blockade of DNAM-1 during the late phase of infec-
tion resulted in significantly fewer Ly49H+ NK cells at day 28,
suggesting that sustained DNAM-1 signaling is required forestablishment of an optimal pool of memory NK cells
(Figure 2C).
Intrinsic Lack of DNAM-1 Impairs Ly49H+ NK Cell
Response to MCMV
In addition to NK cells, DNAM-1 is expressed on CD8+ T cells
and subsets of CD4+ T cells and dendritic cells (DCs) (Dardalhon
et al., 2005; Iguchi-Manaka et al., 2008). Therefore, treatment
with the blocking anti-DNAM-1 might affect the response of
other immune cells during MCMV infection. To determine
whether an intrinsic lack of DNAM-1 affects NK cells, we recon-
stituted lethally irradiated recipient mice with CD45.1+ WT and
CD45.2+Cd226/BMcells and allowedNK cells to reconstitute
in the recipient mice for 5 weeks. At this time, an equivalent fre-
quency ofmatureWT andCd226/NK cells was detected in the
blood and spleen of the chimeric mice, consistent with prior
studies documenting normal development and numbers of NK
cells in Cd226/ mice (Gilfillan et al., 2008). Ly49H+ NK cells
were isolated from the chimeric mice, adoptively transferred
into Ly49H-deficient mice, and then infected with MCMV (Fig-
ure 3A). During the early phase of the response to MCMV infec-
tion, Cd226/ Ly49H+ NK cells were activated comparably to
WT Ly49H+ NK cells (as reflected by upregulation of Sca-1,
CD69, and KLRG1) and WT and Cd226/ Ly49H+ NK cells pro-
duced identical amounts of IFN-g on day 1.5 pi (Figure 3B and
data not shown). Ly49H+ effector and memory NK cells highly
expressed KLRG1 and predominantly displayed a mature
phenotype (CD11b+, CD27, and Ly6Chi) on day 7 and day 25
pi, respectively (Figure 3C). However,Cd226/ Ly49H+ NK cells
showed severe defects in expansion of effector NK cells, as well
as in the generation of long-lived NK cells (Figures 3D and S2).
Cd226/ Ly49H+ NK cells isolated from the MCMV-infected
mice and adoptively transferred into naive Ly49H-deficient
recipient mice expanded poorly when rechallenged withImmunity 40, 225–234, February 20, 2014 ª2014 Elsevier Inc. 227
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Figure 3. DNAM-1 Is Required for Expan-
sion of Effector NK Cells and Differentiation
of Memory NK Cells during MCMV Infection
(A) NK cells were purified from WT and Cd226/
mixed BM chimeric mice. WT and Cd226/
Ly49H+ NK cells (1.5 3 105) were transferred into
Ly49H-deficient mice and infected with 1 3
105 pfu MCMV.
(B) Activation markers CD69 and KLRG1 on
Ly49H+ NK cells at day 1.5 and 7 pi, respectively,
and IFN-g production on day 1.5 pi. Thin and bold
lines represent Cd226/ Ly49H+ and WT Ly49H+
NK cells.
(C) Phenotype of WT and Cd226/ naive, effector
(day 7 pi), and memory (day 25 pi) NK cells.
Expression of KLRG1, CD11b, CD27, and Ly6C on
Ly49H+ NK cells is shown.
(D) The kinetics of the absolute number of Ly49H+
NK cells in blood were represented as the ratio
relative to the number of Ly49H+ NK cells in the
blood on day 0 (before infection). Data are repre-
sentative of three experiments (n = 6–7 mice).
(E) Memory NK cells were isolated from recipient
mice 30 days after primary infection, transferred
into naive Ly49H-deficient mice, and infected with
MCMV. Secondary expansion of Ly49H+ memory
NK cells in the spleen on day 7 after infection with
MCMV was represented as the fold expansion
relative to the number of memory NK cells de-
tected in the spleen of mice adoptively transferred
with an aliquot of Ly49H+ memory NK cells but not
infected with MCMV. Data are pooled from two
experiments (n = 6 mice).
(F and G)WT andCd226/memory NK cells were
purified from recipient mice 25–28 days after pri-
mary infection, and WT and Cd226/ naive NK
cells were purified fromBMchimericmice.WT and
Cd226/ naive and memory Ly49H+ NK cells (13
104) were transferred separately into Ly49H-defi-
cient or DAP12-deficient mice and infected with
MCMV. The copy number of MCMV IE1 gene in
blood on day 3 pi (F) and day 7 pi (G) was analyzed
by quantitative PCR. Data were pooled from two
experiments (n = 6–8 mice per group).
*p < 0.05, **p < 0.01, and ***p < 0.005. Error bars
show SEM. See also Figures S2 and S3.
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NK cells were adoptively transferred into a naive Ly49H-deficient
or DAP12-deficient hosts, they showed an impaired protective
effect against MCMV challenge on days 3 and 7 pi (Figures 3F,
3G, and S3), although MCMV-specific T cell responses are
mounted and decrease the viral burden on day 7 pi (Schlub
et al., 2011). These results demonstrate that DNAM-1 is essential
for the optimal differentiation of effector andmemory Ly49H+ NK
cells duringMCMV infection but is dispensable for the initial acti-
vation of NK cells.
DNAM-1 Signaling Is Mediated by Fyn and PKCh
Previous studies have demonstrated that signaling through
DNAM-1 is mediated by Fyn and PKC (Shibuya et al., 1999; Shir-
akawa et al., 2005), although which PKC isozymes are respon-
sible had not been identified. We speculated that PKCh might
be responsible for DNAM-1-dependent PKC signaling. This pos-
sibility is based on prior studies where phosphorylation of the228 Immunity 40, 225–234, February 20, 2014 ª2014 Elsevier Inc.cytoplasmic motifs of DNAM-1 was assessed in the presence
and absence of PKC (Shibuya et al., 1998; Shirakawa et al.,
2005), kinome analysis after cross-linking of DNAM-1 (Ko¨nig
et al., 2012), transcriptional profiling of PKC isozymes in mouse
and human NK cells (http://www.immgen.org/), and analysis of
PKCq-deficient (Prkcq/) mice after MCMV infection (Tassi
et al., 2008). To address whether Fyn and PKC are directly
involved in downstream signaling of DNAM-1, Cd226/ he-
matopoietic progenitor cells (HPCs) were transduced with retro-
viral vectors encoding WT DNAM-1, a S326F mutant in a PKC-
binding motif, a Y319F mutant in a Fyn-binding site, or a SFYF
mutant with both mutations. Lethally irradiated recipient mice
were reconstituted with the Cd226/ BM cells transduced
with WT or mutant DNAM-1 (hereafter referred to as ‘‘DNAM-1
rescued’’) mixed with WT BM cells. WT DNAM-1-rescued and
Y319F (Fyn-binding) mutant DNAM-1-rescued Cd226/
Ly49H+ NK cells expanded similarly to WT Ly49H+ NK cells in
Ly49H-deficient recipient mice after MCMV infection (Figure 4A).
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Figure 4. DNAM-1 Signaling Is Required for
Optimal Differentiation of Ly49H+ NK Cells
during MCMV Infection
(A and B) NK cells were purified from BM chimeric
mice reconstituted with WT, Cd226/, and
DNAM-1-rescued Cd226/ HPCs. Ly49H+ NK
cells were isolated from chimeric mice and trans-
ferred into Ly49H-deficient mice, and then in-
fected with 1 3 105 pfu MCMV. The number of
Cd226/ and DNAM-1-rescued Ly49H+ effector
NK cells on day 7 pi (A) and memory NK cells on
day 25 pi (B) in the spleen was represented as the
fold expansion relative to the number of WT
Ly49H+ NK cells on days 7 and 25 pi in the spleen.
Data are pooled from two experiments (n = 4 mice
per rescued construct). *p < 0.05.
(C–F) NK cells were purified from BM chimeric
mice of WT and Fyn/ mice or WT and Prkch/
mice. WT and Fyn/ Ly49H+ NK cells (4 3 105
cells) orWT andPrkch/ Ly49H+ NK cells (13 105
cells) were transferred into Ly49H-deficient mice
and infected with MCMV.
(C and E) The kinetics of the absolute number of
Ly49H+ NK cells in blood were represented as the
ratio relative to the number of Ly49H+ NK cells in
blood on day 0 (before infection).
(D and F) Memory NK cells were transferred into
naive Ly49H-deficient mice and infected with
MCMV. Secondary expansion of Ly49H+ memory
NK cells in the spleen on day 7 after infection with
MCMV was represented as the fold expansion
relative to the number of memory NK cells de-
tected in the spleen of mice adoptively transferred
with an aliquot of Ly49H+ memory NK cells but not
infected with MCMV. Data are representative of
two to three experiments (n = 3–5). Error bars show
SEM. *p < 0.05.
See also Figure S4.
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DNAM-1-rescued Cd226/ Ly49H+ NK cells showed a lower
magnitude of initial response compared toWTDNAM-1-rescued
Ly49H+ NK cells (Figure 4A). On the other hand, Cd226/
Ly49H+ NK cells expressing any of the three mutant forms of
DNAM-1 failed to efficiently differentiate into long-lived NK cells
(Figure 4B).
To confirm the roles of Fyn and PKCh in the differentiation of
Ly49H+ NK cells during MCMV infection, we produced mixed
BM chimeras of WT and Fyn-deficient (Fyn/) cells, or WT
and PKCh-deficient (Prkch/) cells, so that WT and Fyn/ or
Prkch/ NK cells would develop in the same environment. After
reconstitution, Ly49H+ NK cells sufficient or deficient in Fyn or
PKCh were purified from mixed BM chimeric mice, transferred
into Ly49H-deficient mice, and infected with MCMV. Fyn-defi-
cient Ly49H+ NK cells proliferated equivalently to WT Ly49H+
NK cells during the first week postinfection, but differentiated
poorly into a memory subset (Figures 4C and S4A); however,
Fyn-deficient memory NK cells did expand when adoptively
transferred into naive Ly49H-deficient recipient mice and rechal-
lenged with MCMV (Figure 4D). In contrast, PKCh-deficient
Ly49H+ NK cells showed a dampened initial response and
impaired differentiation into long-lived NK cells with a defective
secondary MCMV-induced expansion of these memory NK cellswhen transferred into naive Ly49H-deficient recipients (Figures
4E, 4F, and S4B). The results with the DNAM-1-rescued donor
Cd226/ Ly49H+ NK cells are consistent with the phenotypes
of Ly49H+ NK cells deficient in Fyn and PKCh and strongly sug-
gest that the DNAM-1-Fyn signaling axis is required for the effi-
cient generation of memory NK cells but is dispensable for
expansion of both effector NK cells and memory NK cells,
whereas DNAM-1-dependent PKCh signaling is required for
both the expansion of effector NK cells and generation of mem-
ory NK cell.
DNAM-1 on Ly49H+ NK Cells Is Dynamically Regulated
during MCMV Infection
In WT mice, the frequency of Ly49H+DNAM-1 NK cells
increased after MCMV infection in a virus dose-dependent
manner (Figure 5A). The downmodulation of DNAM-1 on
DNAM-1+ NK cells or expansion of DNAM-1 NK cells was
observed only on Ly49H+ NK cells after infection with MCMV;
it was not downmodulated on Ly49H NK cells (Figure 5A).
Moreover, the loss of DNAM-1 was not observed when mice
were infected with a MCMV mutant strain lacking m157
(Figure 5B).
To determine whether the increase of Ly49H+DNAM-1 NK
cells is caused by preferential expansion of Ly49H+DNAM-1Immunity 40, 225–234, February 20, 2014 ª2014 Elsevier Inc. 229
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Figure 5. DNAM-1 on Ly49H+ NK Cells Is
Modulated during MCMV Infection
(A) DNAM-1 on Ly49H+ NK cells in the spleen of
mice infected with MCMV on day 7 pi. Data are
representative of two experiments (n = 2–3 in each
group).
(B) Percentages of DNAM-1-negative NK cells
within the Ly49H+ and Ly49H NK cell subsets in
the blood of mice infected with 5 3 105 pfu WT or
Dm157 MCMV. *p < 0.05 versus the other three
groups.
(C) CellTrace Violet-labeled splenocytes (2.5 3
107) were transferred into DAP12-deficient mice
and infected with 1 3 105 pfu MCMV. Expression
of DNAM-1 on Ly49H+ NK cells in the spleen was
analyzed on days 3 and 6 pi.
Data are representative of three experiments (n =
3–4 mice per time point) (B and C).
(D and E) CD45.1+Ly49H+ NK cells (1 3 105–2 3
105) were transferred into Ly49H-deficient mice
and infected with MCMV.
(D) MFI of DNAM-1 on Ly49H+ NK cells in the
spleen. Data were pooled from six experiments
(n = 3–5 mice per time point). *p < 0.05, **p < 0.01
versus day 0.
(E) DNAM-1 on CD45.1+Ly49H+ memory NK cells
in the spleen on day 35 pi. Data are representative
of more than five experiments.
(F) WT splenocytes (2.5 3 107) were transferred
into DAP12-deficient mice and infected with
MCMV. Cell death of Ly49H+ NK cells was
analyzed by Annexin V staining on days 3 and 6 pi.
Data are representative of three experiments (n =
3–4 mice per experiment). *p < 0.05, **p < 0.01
versus DNAM-1.
Error bars show SEM. See also Figure S5.
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DNAM-1 Regulates the Generation of Memory NK CellsNK cells, WT NK cells labeled with the CellTrace Violet dye
were adoptively transferred into Ly49H-deficient mice. The
transferred NK cells did not undergo homeostatic proliferation
in the recipient in the absence of infection because the
Ly49H-deficient mice express normal numbers of endogenous
NK cells (data not shown). The adoptively transferred DNAM-1
and DNAM-1+ Ly49H+ NK cells divided equivalently early
during MCMV infection (Figure 5C). We observed that the
expression of DNAM-1 on Ly49H+ NK cells was transiently up-
regulated after infection, but thereafter DNAM-1-negative
or -low Ly49H+ NK cells accumulated during the course of
infection (Figure 5D), and consequently most memory NK cells
were DNAM-1 negative (Figure 5E). Interestingly, a higher fre-
quency of DNAM-1+Ly49H+ NK cells stained for Annexin V at
days 3 and 6 pi compared with DNAM-1Ly49H+ NK cells, sug-
gesting that the predominance of DNAM-1Ly49H+ NK cells
might be due to preferential survival of DNAM-1 NK cells (Fig-
ures 5F and S5).
When naive DNAM-1 and DNAM-1+ NK cells were purified
and transferred into Ly49H-deficient hosts and infected with
MCMV, the sorted DNAM-1+ NK cells progressively lost expres-
sion of DNAM-1 (Figure 6). The sorted DNAM-1NK cell popula-
tion transiently upregulated DNAM-1, but over the course of
infection DNAM-1Ly49H+ NK cells accumulated and predomi-
nated at day 28 pi (Figure 6). Similarly, when memory DNAM-1
Ly49H+ NK cells were isolated and adoptively transferred into a230 Immunity 40, 225–234, February 20, 2014 ª2014 Elsevier Inc.Ly49H-deficient naive host and rechallenged with MCMV, there
was transient upregulation of DNAM-1 (data not shown). These
results indicate that DNAM-1 on Ly49H+ NK cells is dynamically
regulated during MCMV infection.
DNAM-1 Ligands Are Upregulated after MCMV Infection
In Vivo
We investigated whether the DNAM-1 ligands are modulated in
the host duringMCMV infection. Although HCMV downregulates
DNAM-1 ligands on human cells infected in vitro (Prod’homme
et al., 2010; Tomasec et al., 2005), changes in DNAM-1 ligand
expression in vivo after MCMV infection had not been deter-
mined. CD155 and CD112 were rapidly upregulated on splenic
DCs and macrophages after MCMV infection (Figure 7A). Infec-
tion of floxed YFP reporter mice with MCMV encoding Cre
demonstrated that a small percentage of DCs andmacrophages
was positive for YFP on days 1 and 3 pi (Figure 7B), consistent
with a previous study using a MCMV encoding GFP (Hsu et al.,
2009). Furthermore, infection with GFP-MCMV revealed that in-
fected DCs andmacrophages highly expressed DNAM-1 ligands
as compared to noninfected cells (Figure 7C). These results sug-
gest that DNAM-1 ligands are upregulated on DCs and macro-
phages during MCMV infection, allowing DNAM-1+Ly49H+ NK
cells to engage DNAM-1 ligand-expressing cells in lymphoid
tissues. Collectively, our findings reveal that DNAM-1 signaling
through Fyn and PKCh works in conjunction with the
Figure 6. DNAM-1– and DNAM-1+ NK Cells Expand and Differentiate
into Memory NK Cells during MCMV Infection
Purified Ly49H+DNAM-1+ or Ly49H+DNAM-1 NK cells (1 3 105) were trans-
ferred separately into DAP12-deficient mice and infected with 13 105 MCMV.
Percentages of Ly49H+DNAM-1+ and Ly49H+DNAM-1 NK cells in blood are
shown. Data are representative of three experiments (n = 4–5 mice). Error bars
show SEM.
Immunity
DNAM-1 Regulates the Generation of Memory NK Cellsm157-specific Ly49H receptor to enhance the immune response
against MCMV and generate long-lived memory NK cells.DISCUSSION
Here, we have demonstrated that DNAM-1 is essential for the
optimal function and differentiation of Ly49H+ NK cells during
MCMV infection. Although the precise molecular mechanisms
underlying adaptive immune features of MCMV-specific NK cells
remain mostly unknown, we have determined that signaling
through DNAM-1 is one of the critical factors for the initial expan-
sion of effector Ly49H+ NK cells, as well as the generation and
secondary expansion of memory Ly49H+ NK cells.
The expansion and generation of memory Ly49H+ NK cells
induced by DAP12-mediated, immunoreceptor tyrosine-based
activation motif (ITAM)-dependent signaling and the kinetics of
the Ly49H+ NK cell response are quite similar to the adaptive im-
mune features of virus-specific CD8+ T cells (Sun et al., 2009).
We have identified Fyn and PKCh as downstream components
of the DNAM-1 transmitted signals necessary for the differentia-
tion of Ly49H+ NK cells during MCMV infection. Remarkably,
these signaling molecules are differentially required at distinct
stages of NK cell differentiation. DNAM-1-induced Fyn signaling
contributed to the efficient generation of memory NK cells but
was dispensable for the initial proliferation of NK cells as well
as the secondary expansion of memory NK cells, whereas the
DNAM-1-PKCh signaling axis was essential for both expansion
of effector NK cells and the efficient generation of memory NK
cells. In T cells, Fyn and Lck are required for optimal T cell recep-
tor (TCR)-mediated signaling (Salmond et al., 2009; Stein et al.,
1992). Fyn-deficient T cells demonstrate a reduced calcium
influx and proliferative responses but normal Akt kinase phos-
phorylation, after engagement of their TCRs because of the func-
tional redundancy of Lck (Salmond et al., 2009). In contrast to
T cells, the role of Src family kinases in NK cells is still not under-stood well. In mouse NK cells, Fyn and Lck are physically and
functionally associated with the DAP12 and Ly49D signaling
complex (Mason et al., 2006), another activating receptor similar
to Ly49H (Smith et al., 1998). Although Fyn-deficient mice
display alternation in their Ly49 repertoire (Lowin-Kropf et al.,
2002), Fyn-deficient Ly49D+ NK cells efficiently lyse YAC-1 and
CHO target cells and secrete IFN-g comparably to WT Ly49D+
NK cells (Mason et al., 2006). Fyn is capable of phosphorylating
DAP12, and Ly49D stimulation reciprocally promotes phosphor-
ylation of Fyn (Mason et al., 2006). Because an activation signal
through DNAM-1 is mediated by Fyn but not Lck (Shibuya et al.,
1999), activation of Fyn through DNAM-1 might contribute to
enhanced Ly49H-induced phosphorylation of DAP12, leading
to optimal signaling for the differentiation of memory Ly49H+
NK cells. Unlike Ly49H+ NK cells deficient in PKCh and
DNAM-1, Fyn-deficient Ly49H+ NK cells mount a normal prolifer-
ation responses to MCMV, similar to the intact, albeit reduced,
proliferation of Fyn-deficient T cells responding to antigenic
challenge (Stein et al., 1992).
DNAM-1 costimulates the proliferation of CD8+ T cells (Nabe-
kura et al., 2010) and DNAM-1-induced activation is partly medi-
ated by PKC (Shibuya et al., 1998; Shirakawa et al., 2005). Fu
et al. (2011) demonstrated a pivotal role of PKCh in the prolifer-
ation, calcium influx, and NF-kB signaling in T cells, and PKCh
and PKCq share functional redundancies in T cells. In contrast,
PKCq in NK cells is dispensable for cytotoxicity and control of
early MCMV infection (Tassi et al., 2008). Although our findings
do not exclude the possibility that other PKC isozymes partici-
pate in NK cell activation, our results clearly demonstrate a crit-
ical role of PKCh in the adaptive immune features of NK cells
responding to MCMV infection. With regard to the virus-specific
expansion of effector NK cells, the phenotypes of Ly49H+ NK
cells deficient in DNAM-1, Fyn, and PKCh during MCMV infec-
tion are shared with the antigen-specific proliferation of T cells
deficient in these molecules (Fu et al., 2011; Nabekura et al.,
2010; Stein et al., 1992). However, the role of DNAM-1 in the
differentiation of memory NK cells and T cells has not been
appreciated previously. Previous studies have reported that a
deficiency of Fyn has no significant impact on survival of naive
and memory T cells (Seddon and Zamoyska, 2002) and that
PKCh-deficient T cells exhibit identical sensitivity to cell death
as WT T cells (Fu et al., 2011). Thus, NK cells and T cells may
possess unique cell-specific molecular requirements for the
generation and persistence of memory cells.
An optimal differentiation of MCMV-specific NK cells is gov-
erned not only by the distinct downstream signaling components
of DNAM-1 but also by the temporal regulation of DNAM-1
signaling during the infection. Because DNAM-1 ligands are
constitutively expressed by hematopoietic and epithelial cells
(Aoki et al., 1997; Nabekura et al., 2010; Ravens et al., 2003), up-
regulation of either DNAM-1 or its ligands might enable Ly49H+
NK cells bearing DNAM-1 to receive activating signal through
DNAM-1 in addition to Ly49H during MCMV infection. Infection
of human cells with HCMV in vitro results in the downregulation
of DNAM-1 ligands (Prod’homme et al., 2010; Tomasec et al.,
2005). In contrast, DNAM-1 ligands on DCs and macrophages
are strongly upregulated by signaling through TLR3 and TLR9
(Kamran et al., 2013; Pende et al., 2006), which are essential
for innate immune defense against MCMV infection (TabetaImmunity 40, 225–234, February 20, 2014 ª2014 Elsevier Inc. 231
AB
C Figure 7. DNAM-1 Ligands Are Upregulated
after MCMV Infection In Vivo
(A) WTmice were infected with 13 106 pfu MCMV.
Expression of CD155 and CD112 on hematopoi-
etic cells in the spleen of infected mice on days 1
and 3 pi was analyzed by flow cytometry. NK cells
(TCRbNK1.1+), NKT cells (TCRb+NK1.1+), CD4+
T cells (TCRb+CD4+), CD8+ T cells (TCRb+CD8a+),
B cells (CD11bB220+), DCs (CD11chiI-AE+),
granulocytes (Gr; CD11b+Gr-1hi), and macro-
phages (Mf; CD11b+Gr-1lo) were assessed.
(B) Cre-dependent YFP reporter mice were in-
fected with 2 3 104 pfu Cre-MCMV. YFP+
hematopoietic cells in the spleen of infected mice
on days 1 and 3 pi were analyzed.
(A and B) Data are representative of two experi-
ments (n = 3 mice per time point). *p < 0.05 versus
uninfected.
(C) WT mice were infected with 1 3 106 pfu GFP-
MCMV. Expression of CD155 and CD112 on GFP
and GFP+ DCs and macrophages in the spleen
was analyzed. Data are pooled from three experi-
ments (n = 5–6mice per time point). *p < 0.05, **p <
0.01 versus GFP. Error bars show SEM.
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rapidly upregulated on DCs in MCMV-infected mice, whereas
DNAM-1 on Ly49H+ NK cells is temporally upregulated at the
same timing. One possible scenario is that the kinetics of expres-
sion of DNAM-1 enable Ly49H+ NK cells to receive adequate
DNAM-1 signaling in the context of upregulated DNAM-1 ligands
on infected DCs during MCMV infection, consequently allowing
Ly49H+ NK cells to control viral burden in the early phase, as
well as to receive sustained DNAM-1 signaling for optimal
expansion and differentiation of memory NK cells. Our findings
indicate that cooperative signaling through multiple activating
receptors regulates the adaptive immune features of NK cells.
Further studies of the signaling adaptor molecules, cytokines,
transcriptional factors, and activating and inhibitory receptors
to more deeply understand the molecular mechanisms underly-
ing the differentiation of NK cells will pave the way for the devel-
opment of new NK cell-based vaccines and therapies against
infectious diseases and malignancies.
EXPERIMENTAL PROCEDURES
Mice and MCMV
C57BL/6 and congenic CD45.1+ mice were purchased from the National Can-
cer Institute. DNAM-1-deficient (Cd226/) mice (Iguchi-Manaka et al., 2008)
on a C57BL/6 background were bred and maintained at University of Tsukuba
in accordance with the guidelines of the Institutional Review Committee of Uni-
versity of Tsukuba. Congenic CD45.1+, Fyn (Fyn/)-deficient (Stein et al.,
1992), Ly49H-deficient (Fodil-Cornu et al., 2008), DAP12 (Tyrobp/)-deficient
(Bakker et al., 2000), flox-stop-flox ROSA26-YFP, Cre-dependent YFP re-
porter mice (Srinivas et al., 2001), and PKCh (Prkch
/
)-deficient (Fu et al.,
2011) mice on a C57BL/6 background were maintained at the University of
California, San Francisco and The Scripps Research Institute in accordance
with the guidelines of the Institutional Animal Care and Use Committee. Mixed
BM chimeric mice were generated as described previously (Sun et al., 2009).
Smith strain WT MCMV, Dm157 MCMV, and GFP-MCMV were prepared in
C57BL/6 3T3 cells, and Cre-MCMV was prepared in BALB/c mice as
described previously (Bubic et al., 2004; Cicin-Sain et al., 2005; Henry et al.,
2000). Mice were infected by intraperitoneal injection of 1 3 105, 5 3 105,
and 1 3 106 plaque-forming units (pfu) WT MCMV, Dm157 MCMV, GFP-
MCMV, respectively, or 2 3 104 pfu Cre-MCMV. In some experiments, mice232 Immunity 40, 225–234, February 20, 2014 ª2014 Elsevier Inc.were inoculated intraperitoneally with 100 mg of TX42.1, a nondepleting,
neutralizing rat mAb against mouse DNAM-1 (Nabekura et al., 2010) or an iso-
type-matched rat IgG2a on the day before infection and day 3 pi, or days 7, 14,
and 21 pi.
NK Cell Enrichment and Adoptive Transfer
NK cells were enriched by incubating splenocytes with purified rat mAbs
against mouse CD4, CD5, CD8, CD19, Gr-1, and Ter119, followed by anti-
rat IgG antibodies conjugated to magnetic beads (QIAGEN). NK cells were en-
riched from BM chimeric mice 5 weeks or later after BM transplantation.
DNAM-1+ and DNAM-1 NK cells or WT and Cd226/ NK cells were purified
by using a FACSAria III (BD Biosciences). Ly49H+ NK cells (1 3 105–4 3 105)
were injected intravenously into syngeneic Ly49H-deficient or DAP12-defi-
cient recipient mice on the day before MCMV infection. 2.53 107 splenocytes
were labeled with 10 mM CellTrace Violet according to the manufacturer’s in-
structions (Invitrogen) before intravenous injection of adoptively transferred
NK cells.
Transplantation of Transduced HPCs
Retroviral vectors MCSV2.2-IRES-GFP encoding WT DNAM-1, DNAM-1
mutated at a PKC-binding site (S326F mutant), DNAM-1 mutated at a Fyn-
binding site (Y319F mutant), and SFYF mutant DNAM-1 with both mutations
(Shirakawa et al., 2006) were prepared by calcium phosphate cotransfection
of these retroviral constructs and expression vectors encoding MuLV gag-
pol and vesicular stomatitis virus G protein into 293T cells according to the
manufacturer’s instructions (Promega). Retroviruses were concentrated by
overnight centrifugation and viral titers were determined by infection of 293T
cells. BM cells were isolated from Cd226/ mice, and HPCs were enriched
by Ficoll-Paque gradient centrifugation of BM cells and then incubated with
purified rat mAbs against mouse CD4, CD5, CD8, CD11b, CD19, Gr-1,
Ter119, and NKp46, followed by anti-rat IgG antibodies conjugated to mag-
netic beads (QIAGEN). HPCs were cultured in StemPro34 (Invitrogen) in the
presence of 10 ng/ml mouse IL-3, 30 ng/ml human IL-6, and 50 ng/ml mouse
stem cell factor (PeproTech) on Retronectin-coated culture plates (Clontech).
HPCs were transduced with retroviruses on days 1 and 2 (Nabekura et al.,
2006). Transduced Cd226/ HPCs (1 3 103–10 3 103) were mixed with
CD45.1+CD45.2+ WT HPCs and transplanted into lethally irradiated recipient
mice (550 rad 3 2, 4 hr interval) on day 2.5.
Flow Cytometry
Fc receptors were blocked with 2.4G2 mAb before surface or intracellular
staining with the indicated mAbs or isotype-matched control antibodies (BD
Biosciences, eBioscience, or BioLegend). For measuring apoptosis, freshly
Immunity
DNAM-1 Regulates the Generation of Memory NK Cellsisolated splenocytes were stained with antibodies against cell surface mole-
cules and APC-conjugated Annexin V (BD Biosciences) according to the man-
ufacturer’s protocol. Samples were acquired on an LSRII or a FACSCalibur
(BD Biosciences) and analyzed with FlowJo software (Tree Star).
Measurement of MCMV Load
C57BL/6 mice were inoculated intraperitoneally with 100 mg of TX42.1, a
neutralizing mAb against DNAM-1, or an isotype-matched rat IgG2a on the
day before infection, followed by infection with 5 3 105 pfu MCMV. On day 3
pi, one lobe of each liver and spleenwere homogenized in DMEM. Cell homog-
enates were plated on C57BL/6 3T3 cells in 10-fold serial dilutions and incu-
bated for 2 hr at 37C. DMEM with 10% FCS and 0.75% carboxymethyl
cellulose was added and samples were incubated for 9 days. Plaques were
counted under a light microscopy. Viral titers in the spleen were calculated
for the whole organ and titers in the liver were adjusted for weight of the tissue.
The copy number of MCMV IE1 gene in DNA prepared from peripheral blood
on days 3 and 7 pi was determined by quantitative PCR analysis with a
SYBR green master mix reagent (Invitrogen) and the following primer pair:
MCMV IE1 forward, 50-AGCCACCAACATTGACCACGCAC-30; MCMV IE1
reverse, 50-GCCCCAACCAGGACACACAACTC-30. A plasmid encoding
MCMV IE1 was used for the standard curve.
Ex Vivo Stimulation of NK Cells
One million splenocytes were cocultured with 1 3 105 RMA transfectants ex-
pressing m157, CD155, or m157 and CD155 for 6 hr at 37C in the presence of
PE-conjugated anti-CD107a mAb, GolgiStop, and GolgiPlug (BD Biosci-
ences), followed by staining for surface molecules and intracellular IFN-g.
Statistical Methods
Student’s t test was used to compare results. The Mann-Whitney U test was
used to compare groups in a PCR-based viral titer assay. p < 0.05 was consid-
ered statistically significant.
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